Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
August 19, 2016
-
INTERVIEW Interview: Ex-Astellas Boss Takenaka Urges Mid-Size Makers to Be More Open to Academia in Pathological Research
August 18, 2016
-
REGULATORY AMED Taking Steps toward “Aggressive Intellectual Property Management”: IP Department Head
August 18, 2016
-
BUSINESS CEO of Teva-Takeda JV Confident on Handling Both Long-Listed Brands, Generics
August 17, 2016
-
BUSINESS Mitsubishi Tanabe to Focus on Sales Turnaround for Canaglu, Eyes Diabetes and Nephrology Sales of 100 Bil. Yen
August 17, 2016
-
REGULATORY MHLW OKs First Generics for Tracleer, 6 Other APIs towards December Listing
August 16, 2016
-
BUSINESS Teijin Gets Japan Rights to Versartis’ Growth Hormone Deficiency Treatment
August 15, 2016
-
REGULATORY MHLW Study Group to Look at Measures to Popularize Biosimilars, Increase Efficiency in Development and Manufacturing
August 12, 2016
-
REGULATORY Startup Promotion Guide to Support Major Companies as well: MHLW Official
August 10, 2016
-
REGULATORY JMA, MHLW Say Possible Opdivo Re-Pricing Is Emergency Step, Won’t Make It Slippery Slope to Annual Revisions
August 9, 2016
-
ORGANIZATION EFPIA Japan Calls for Relaxation of Japanese Vaccine Regulations: Vaccine Subcommittee Head
August 9, 2016
-
REGULATORY MHLW Panel OKs Opdivo for RCC, ASKA’s Hepatic Encephalopathy Drug
August 8, 2016
-
INTERVIEW Japan Biosimilar Association Aims to Share Knowledge and Experience to Popularize the Use of Biosimilars: Director General
August 5, 2016
-
REGULATORY Kipres/Singulair to Face Generic Onslaught in Dec.; Competition to Hit Tracleer, Too
August 4, 2016
-
ACADEMIA 3 Scientific Societies to Set Up HBOC Body to Build BRCA Gene Database
August 4, 2016
-
REGULATORY MHLW to Gauge Possible Deregulation of Plasma Export Restriction towards FY2018: Blood Division Chief
August 3, 2016
-
BUSINESS Japan Market Grows in April-June on Hep C Meds, Opdivo: IMS
August 2, 2016
-
BUSINESS Takeda to Revamp R&D Organization, Eyes Consolidated Research Sites in Japan, US
August 1, 2016
-
REGULATORY Pricy Meds Issue Takes a Step Forward with 2-Faceted Proposal
July 29, 2016
-
REGULATORY Chuikyo to Discuss Out-of-Cycle Re-Pricing for Opdivo, but JMA Turns Wary
July 28, 2016
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…